Stanford University
Showing 4,951-5,000 of 13,016 Results
-
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
On Leave from 2026-09-01 To 2026-12-01BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence (AI) techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multiomic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include data science/AI-powered prediction modeling of survival, treatment response, cancer recurrence, and metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her goal is to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.
-
Reem Itani, MD, MACM
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Itani is board certified in sleep medicine and general pediatrics and has additional fellowship training in pediatric pulmonology and sleep medicine.
Dr. Itani diagnoses and treats a wide range of sleep disorders in adults and children.
Dr. Itani’s research interests include medical education and patient compliance and education. Her other research interests have included sleep consequences of Prader-Willi syndrome and congenital central hypoventilation syndrome.
Dr. Itani has published her research in peer-reviewed journals including Journal of Clinical Sleep Medicine, Current Neurology and Neuroscience Reports, Medical Teacher, and Brain & Development. She has presented to her peers at national and regional meetings, including the Institute for Healthcare Improvement, the Innovations in Medical Education Conference, and the American Thoracic Society.
Dr. Itani is a fellow of the American Academy of Pediatrics and a member of the American Thoracic Society and the American College of Chest Physician. -
Michael Iv
Clinical Professor, Radiology
Current Research and Scholarly InterestsMy clinical and research interests include brain tumor and vascular imaging in both the adult and pediatric populations, incorporating advanced MR imaging techniques and analyses using qualitative and quantitative methods.
-
Rebecca Ivancie
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsMedical Education Projects
- PHM Fellows and their training in Community Pediatric Hospital Medicine
Clinical Research: Using PHIS database to study MIS-C and Kawasaki disease -
Fabio Iwamoto, MD
Professor of Neurology and Neurological Sciences (Adult Neurology) and of Neurosurgery (Adult Neurosurgery)
BioDr. Fabio Iwamoto is a board-certified, fellowship-trained neuro-oncologist at Stanford Health Care. He is also a professor in the Department of Neurology & Neurological Sciences, Division of Neuro-Oncology, and a professor of neurosurgery in the Department of Neurosurgery, Division of Neurosurgical Oncology at Stanford University School of Medicine.
Dr. Iwamoto cares for brain and spinal cord tumors, guiding patients from diagnosis through treatment and follow-up. He specializes in managing cancer that has spread to the brain or spinal cord, working with multiple specialists to develop individualized treatment plans. He also has expertise treating tumors called gliomas, including glioblastomas. Throughout the patient journey, Dr. Iwamoto addresses cancer-related complications, such as cancer therapy side effects, numbness, and memory problems. He strives to deliver the highest level of compassionate, patient-centered care, supporting patients and families through complex decisions and challenging moments.
Dr. Iwamoto’s research focuses on developing and evaluating innovative treatments for brain tumors, particularly gliomas and glioblastomas. He studies immunotherapies, targeted therapies, and novel therapy combinations to improve tumor treatment. He leads several national and international clinical trials with the goal of bringing promising discoveries from the laboratory to patients.
Dr. Iwamoto has authored many publications in leading journals, including Nature Cancer, Nature Medicine, Neuro-Oncology, and the Journal of Clinical Oncology. He has published several book chapters on key topics in neuro-oncology, including emerging glioma treatments and the diagnosis and management of central nervous system tumors. He has also shared his expertise and research findings around the world at meetings of the American Society of Clinical Oncology, American Association for Cancer Research, and international neuro-oncology forums. -
Sarah Izabel
Ph.D. Student in Neurosciences, admitted Summer 2022
SGSI Course Assistant, Vice Provost for Graduate EducationBioSarah was born and raised in Brazil where she attended law school before moving to the United States and shifting her interest to Neuroscience. She completed majors in Biology and Psychology at Virginia Commonwealth University (VCU) in 2020. At VCU, Sarah was part of the NIH-IMSD program and worked on uncovering mechanisms of axonal pathology in the lab of Dr. Jeff Dupree. She also worked with a clinical sample to identify the effects of income insecurity on decision-making in people with cocaine use disorder (CUD), in the lab of Dr. James Bjork. After graduating, Sarah went to the National Institutes of Health (NIH) as a UGSP Research Fellow and characterized a progranulin knockout mouse model in the lab of Dr. Alan Koretsky. She returned to her clinical research work in her second year at NIH in the lab of Dr. Vijay Ramchandani, where she worked to understand the relationship between neurological domains underlying Alcohol Use Disorder (AUD). At Stanford, Sarah is interested in treating and managing neuropsychiatric disorders and increasing access to participation in clinical research studies. Sarah is a RAISE fellow, a NIDA START Fellow, and an intern project manager for the Recovery Incentives Program.
-
Lisa M. Jack
Academic Prog Prof 2, Emergency Medicine
Current Role at StanfordPrimary role at Stanford is to support research efforts in the Department of Emergency Medicine.
Goals include building research infrastructure to support all EMed investigators, leveraging the strength of Stanford University to produce high-impact and innovative emergency care research, and supporting the efforts to become a national leader in academic emergency medicine research.
Previously involved with supporting the efforts of the Twin Registry at Stanford - a valuable resource for research into the influences of genetics on a variety of traits and conditions. -
Robert K. Jackler, MD
Edward C. and Amy H. Sewall Professor, Emeritus
Current Research and Scholarly InterestsSince the early 2000s, study of tobacco industry marketing has become my primary field of research. Motivated by the lack of a comprehensive and well-organized compendium of tobacco advertisements, and the relative paucity of scholarly research analyzing the marketing practices of the industry, I chose to focus my research on advertising. The overarching purpose of my research has been to reveal the behavior of the tobacco industry in recruiting and retaining its consumers with the goal of infor
-
Kelsea Jackson, PhD
Health Equity Clerkship Program Manager, School of Medicine - Student Affairs
Current Role at StanfordREACH Clerkship Program Manager
-
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
Current Research and Scholarly InterestsDr. Jackson’s lab studies how primary cilia organize hormone, metabolite, and growth factor signaling in metabolic tissues and how their disruption causes obesity and diabetes. A second focus is defining the KRAS driven secreted factor networks that rewire the tumor microenvironment in lung and pancreatic cancers to promote immune evasion and therapeutic resistance. This work is revealing new secreted drug targets and combination strategies for precision oncology and metabolic disease.
-
Benjamin Richard Jacob
Clinical Assistant Professor, Medicine
BioBenjamin Jacob, MD, is a Clinical Assistant Professor in the Division of Hospital Medicine and Stanford School of Medicine. He obtained his MD from the University of Texas Southwestern in Dallas, TX. He then completed his Internal Medicine/Pediatrics residency at The Ohio State University, before joining the Oncology Hospitalist program at Stanford. His clinical interests include transitions of care around the end of life, medical humanities, ethics and medical education.
-
Charlotte D. Jacobs M.D.
Drs. Ben and A. Jess Shenson Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsClinical Interests: general oncology, sarcomas. Research Interests: clinical trials in solid tumors.
-
Lisa Robin Jacobs, MD, MBA
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Jacobs is a child, adolescent & adult psychiatrist in private practice in Menlo Park, CA and an Adjunct Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences of the Stanford University School of Medicine. She serves as the Assistant Director of The Pegasus Physician Writers at Stanford and is the Editor at Large of The Pegasus Review. She eared a BA from Cornell University, an MBA from the University of Rochester, and completed medical school at Brown University.
-
Christine Jacobs-Wagner
Dennis Cunningham Professor, Professor of Biology and of Microbiology and Immunology
BioChristine Jacobs-Wagner is a Dennis Cunningham Professor in the Department of Biology and the ChEM-H Institute at Stanford University. She is interested in understanding the fundamental mechanisms and principles by which cells, and, in particular, bacterial cells, are able to multiple. She received her PhD in Biochemistry in 1996 from the University of Liège, Belgium where she unraveled a molecular mechanism by which some bacterial pathogens sense and respond to antibiotics attack to achieve resistance. For this work, she received multiple awards including the 1997 GE & Science Prize for Young Life Scientists. During her postdoctoral work at Stanford Medical School, she demonstrated that bacteria can localize regulatory proteins to specific intracellular regions to control signal transduction and the cell cycle, uncovering a new, unsuspected level of bacterial regulation.
She started her own lab at Yale University in 2001. Over the years, her group made major contributions in the emerging field of bacterial cell biology and provided key molecular insights into the temporal and spatial mechanisms involved in cell morphogenesis, cell polarization, chromosome segregation and cell cycle control. For her distinguished work, she received the Pew Scholars award from the Pew Charitable Trust, the Woman in Cell Biology Junior award from the American Society of Cell Biology and the Eli Lilly award from the American Society of Microbiology. She held the Maxine F. Singer and William H. Fleming professor chairs at Yale. She was elected to the Connecticut academy of Science, the American Academy of Microbiology and the National Academy of Sciences. She has been an investigator of the Howard Hughes Medical Institute since 2008.
Her lab moved to Stanford in 2019. Current research examines the general principles and spatiotemporal mechanisms by which bacterial cells replicate, using Caulobacter crescentus and Escherichia coli as models. Recently, the Jacobs-Wagner lab expanded their interests to the Lyme disease agent Borrelia burgdorferi, revealing unsuspected ways by which this pathogen grows and causes disease -
Gunilla B Jacobson
Technical & Strategic Director, Cyclotron, Rad/Precision Health and Integrated Diagnostics
Current Role at StanfordTechnical and Strategic Director, Cyclotron and Radiochemistry
-
Tristan Jafari
MD Student, expected graduation Spring 2031
BioTristan Jafari is a first-year MD student at Stanford University School of Medicine and a Knight-Hennessy and Samvid Scholar. Tristan graduated summa cum laude in biochemistry from the University of Washington as a Truman Scholar and completed a Masters in Philosophy in Population Health Sciences as a Gates Cambridge Scholar at the University of Cambridge.
